pancreaticobiliary cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with unresectable or reccurent pancreaticobiliary cancer Patients aged 70 years or over when they provide consent Patients who receive or plan to receive chemotherapy Patients with written informed consent
Exclusion criteria
Exclusion criteria: Patients considered inappropriate for participation by the attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evalutaion of what tools are effective to decide treatment and to predict efficacy and safety of chemotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Relation to the scores of CGA and as follows; Overall survival, Progression free survival, duration of treatment, adverse event | — |
Countries
Japan
Contacts
Graduate School of Medicine, The Tokyo University Department of Gastroenterology